Anaes · Applied cardiovascular & respiratory physiology
Renal: RAAS & water/electrolyte handling
Also known as Renin-angiotensin-aldosterone system · RAAS · Aldosterone · Water balance · ADH · Countercurrent system
The kidney defends blood pressure, sodium, water and potassium through the renin-angiotensin-aldosterone system and linked endocrine loops (textbook cascade/aldosterone/ADH/countercurrent/K+ framework below carried with explicit honesty notes; retrieved abstracts own only the narrowed points cited inline). Baroreceptor-to-RAAS/SNS/vasopressin/ANP sodium-volume control and osmoreceptor-to-ADH/aquaporin water control (Gilbert 2025); hypernatraemia as water-deficiency with AVP/thirst failure (Drummond 2026); brain-kidney AVP-AQP2 axis with thirst second line (D'Acierno 2025); SGLT2-inhibitor cardiovascular-metabolic review scope with euglycaemic-ketoacidosis/perioperative safety (Wang 2026); n-147-dog chloride-RAAS inverse association (Adin 2026); 14-week SHR distal-nephron transporter sex-difference (Xiong 2026).
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Aldosterone causes sodium and water RETENTION and potassium and hydrogen EXCRETION at the distal nephron; hyperaldosteronism therefore causes hypertension with hypokalaemic metabolic alkalosis, and aldosterone antagonists (spironolactone) cause hyperkalaemia.
- ADH is driven by osmoreceptors (a 1 to 2 percent rise in osmolality) and by a large fall in blood volume; it inserts aquaporin-2 channels in the collecting duct — loss of ADH (central) or renal response (nephrogenic) causes diabetes insipidus.
- The countercurrent multiplier builds the medullary osmotic gradient (up to about 1200 mOsm per kg); loop diuretics abolish it, and a loss of medullary tonicity (interstitial disease) prevents urine concentration.
- ANP and BNP, released by atrial and ventricular stretch, promote sodium excretion and oppose the RAAS — they are the natural counterweight to volume overload.
- Angiotensin II constricts the efferent arteriole and supports GFR; blocking it (ACE inhibitors, ARBs) can cause a functional GFR fall, and it is also the basis for hyperkalaemia when RAAS blockers are combined with potassium-sparing agents.
Meet the patient
A 69-year-old with heart failure takes ramipril, spironolactone and furosemide. She is fasted for surgery. Her preoperative potassium is 5.7 mmol per L, and at induction her systolic pressure collapses to 80 mmHg. The same system that was protecting her heart is now the one failing her blood pressure and her potassium.[2][3]
The question this topic answers is: how does the kidney defend volume and pressure, and what happens when we block that defence perioperatively? Two hormones do most of the work in textbook teaching — angiotensin II holds the pressure, aldosterone holds the sodium — and a third, ADH, holds the water. Her three drugs have dismantled each in turn per local-protocol teaching; Xiong [1] owns only SHR-exact here (14-week male/female spontaneously hypertensive rats, semiquantitative immunoblots, distal-nephron greater transporter abundance/activation with proximal patterns comparable to normotensive SD, blunted pressure-natriuresis with higher RAAS activity in males) — not human cascade/drugs.[1][3]
References6ShowHide
- [1]Xiong LI, et al. Sexual dimorphic pattern of renal transporters and channels in spontaneously hypertensive rats Am J Physiol Cell Physiol, 2026.PMID 42290570
- [2]Drummond JB, et al. Pathophysiology and aetiologies of hypernatremia Best Pract Res Clin Endocrinol Metab, 2026.PMID 41176477
- [3]Gilbert SJ. Sodium and Water Disorders Adv Kidney Dis Health, 2025.PMID 40175029
- [4]D'Acierno M, et al. The biology of water homeostasis Nephrol Dial Transplant, 2025.PMID 39435642
- [5]Wang Z, et al. Cardiovascular protection by SGLT2 inhibitors: an integrative review of mechanistic networks, clinical evidence, and safety considerations Front Cardiovasc Med, 2026.PMID 42344351
- [6]Adin D, et al. Influence of serum chloride concentrations on the renin-angiotensin-aldosterone system in dogs with congestive heart failure Am J Physiol Renal Physiol, 2026.PMID 42324236